Abstract
Efficacy and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) Prophylaxis in Patients with Severe Hemophilia a and Comorbidities: A Post Hoc Analysis of PROTECT VIII Data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have